The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.

Wolff, F; Leisch, M; Greil, R; Risch, A; Pleyer, L; CELL COMMUN SIGNAL. 2017; 15(1): 13

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

Ludwig, H; Weisel, K; Petrucci, MT; Leleu, X; Cafro, AM; Garderet, L; Leitgeb, C; Foa, R; Greil, R; Yakoub-Agha, I; Zboralski, D; Vauléon, S; Dümmler, T; Beyer, D; Kruschinski, A; Riecke, K; Baumann, M; Engelhardt, M; Leukemia. 2017; 31(4):997-1000

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.

Huemer, F; Dejaco, M; Grabmer, C; Melchardt, T; Neureiter, D; Mayer, G; Egle, A; Greil, R; Weiss, L; Wien Klin Wochenschr. 2017; 129(3-4):-144

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.

Egle, A MEMO-MAG EUR MED ONC. 2017; 10(1): 8-12.

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.

Aberger, F; Hutterer, E; Sternberg, C; Del Burgo, PJ; Hartmann, TN; Cell Commun Signal. 2017; 15(1): 8

SABCS 2016: systemic therapy for metastatic breast cancer

Gampenrieder, SP; Rinnerthaler, G; Greil, R MEMO-MAG EUR MED ONC. 2017; 10(2): 86-89.

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study

Almeida, AM; Prebet, T; Itzykson, R; Ramos, F; Al-Ali, H; Shammo, J; Pinto, R; Maurillo, L; Wetzel, J; Musto, P; Van De Loosdrecht, AA; Costa, MJ; Esteves, S; Burgstaller, S; Stauder, R; Autzinger, EM; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez-Campelo, M; Thepot, S; Ades, L; Sperr, WR; Valent, P; Fenaux, P; Sekeres, MA; Greil, R; Pleyer, L INT J MOL SCI. 2017; 18(4): 837

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.

Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Hackl, H; Greil, R; Barth, J; Rummel, M; Ann Hematol. 2017; 96(7): 1155-1162.

Amb a 1 isoforms: Unequal siblings with distinct immunological features.

Wolf, M; Twaroch, TE; Huber, S; Reithofer, M; Steiner, M; Aglas, L; Hauser, M; Aloisi, I; Asam, C; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Jahn-Schmid, B; Wallner, M; Ferreira, F; Allergy. 2017; 72(12): 1874-1882.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.

Rohner, E; Bütikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Garone, D; Moore, RD; D’Souza, G; Goedert, JJ; Achenbach, C; Gill, MJ; Kitahata, MM; Patel, P; Silverberg, MJ; Castilho, J; McGowan, C; Chen, YA; Law, M; Taylor, N; Paparizos, V; Bonnet, F; Verbon, A; Fätkenheuer, G; Post, FA; Sabin, C; Mocroft, A; Moing, VL; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Antinori, A; Quiros-Roldan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Barger, D; Raben, D; Clifford, GM; Franceschi, S; Brockmeyer, N; Chakraborty, R; Egger, M; Bohlius, J; Clin Infect Dis. 2017; 65(8):-1326.